Evidence map›Paper›PMID 41249164›Full record

ArticleNPJ Regenerative medicine2025

Long noncoding RNA LncBAR enhances BRG1 protein to promote cardiomyocyte cell cycle progression and cardiac repair.

Jun Li, Huanhuan Cai, Yufan Chen, Ruiqi Pi, Lilin Xiang, Zhibing Lu, Yan Zhou, Li Wang

Abstract read
In one paragraph

Article in NPJ Regenerative medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jun Li *Department of Cardiology, Medical Research Institute, Zhongnan Hospital of Wuhan University; Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, China.
Huanhuan Cai *Department of Cardiology, Medical Research Institute, Zhongnan Hospital of Wuhan University; Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, China.
Yufan ChenDepartment of Cardiology, Medical Research Institute, Zhongnan Hospital of Wuhan University; Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, China.
Ruiqi PiDepartment of Cardiology, Medical Research Institute, Zhongnan Hospital of Wuhan University; Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, China.
Lilin XiangDepartment of Cardiology, Medical Research Institute, Zhongnan Hospital of Wuhan University; Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, China.
Zhibing LuDepartment of Cardiology, Medical Research Institute, Zhongnan Hospital of Wuhan University; Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, China. luzhibing@whu.edu.cn.
Yan ZhouHubei Provincial Research Center for Basic Biological Sciences; Department of Stomatology, Medical Research Institute, Zhongnan Hospital of Wuhan University; Frontier Science Center of Immunology and Metabolism, Wuhan University, Wuhan, China. yan.zhou@whu.edu.cn.
Li WangDepartment of Cardiology, Medical Research Institute, Zhongnan Hospital of Wuhan University; Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, China. liwang2020@whu.edu.cn.

Funding

Fundamental Research Funds for the Central Universities in China 2042022kf0052, 2042022dx0003Key Technologies Research and Development Program 2022YFA0806603Major Scientific and Technological Project of Hubei Province 2022ACA005National Key Research and Development Program of China Stem Cell and Translational Research 2021YFA1102500National Natural Science Foundation of China 32270876National Natural Science Foundation of China 32470787, 92068107 and 32070728Natural Science Foundation of Hubei Province 2023AFA059
6 · The paper itself

Abstract

The mammalian heart retains regenerative capacity during the early postnatal period, but this ability declines as it matures. Enhancing cardiomyocyte proliferation represents a key therapeutic approach to promote heart regeneration and repair, yet the molecular mechanisms remain elusive. Here, we identified LncBAR (BAF complex-associated lncRNA) as a critical regulator of cardiac regeneration. LncBAR expression declines during heart development but is upregulated following cardiac injury. Loss of LncBAR impairs cardiomyocyte growth, suppresses cell cycle gene expression, and diminishes heart regeneration, as evidenced by reduced cytokinesis and cardiac function. Conversely, cardiac specific overexpression of LncBAR restores cardiomyocyte proliferation and enhances cardiac regeneration, especially in adult myocardial infarction model. Mechanistically, LncBAR interacts with Brg1, stabilizing BRG1 protein level and activating cell cycle progression to drive cardiomyocytes proliferation. Collectively, our study identified LncBAR as a crucial regulator for heart regeneration, highlighting the LncBAR-BRG1 axis as a promising therapeutic strategy for cardiac repair.

Identifiers

PMID41249164
PMCPMC12623768

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.